Clinical Trial Update: A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen [Phase 2]

View source ↗

Summary

A Phase II clinical study protocol evaluating a second-line liposomal irinotecan combination regimen for advanced biliary tract cancers; currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Liposomal irinotecan (Onivyde) (irinotecan liposome)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Biliary Tract Cancer (BTC) | Phase 2 | Status: NOT_YET_RECRUITING